ARPO

Aerpio Pharmaceuticals, Inc. ARPO

Trading inactive

ARPO
Aerpio Pharmaceuticals, Inc. KRON
Kronos Bio, Inc. SGTX
Sigilon Therapeutics, Inc. ALVR
AlloVir, Inc. TCRR
TCR2 Therapeutics Inc. SYRE
Spyre Therapeutics, Inc. BLUE
bluebird bio, Inc. ERYP
ERYTECH Pharma S.A. HTBX
Heat Biologics, Inc. RPHM
Reneo Pharmaceuticals, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ARPO KRON SGTX ALVR TCRR SYRE BLUE ERYP HTBX RPHM
6M 0.00 % -11.13 % 51.62 % -44.83 % 48.18 % 59.29 % -42.81 % 31.98 % 0.00 % 4.60 %
YTD 0.00 % -9.29 % 400.45 % -5.22 % 48.00 % 1.72 % -42.81 % 128.54 % 0.00 % 9.64 %
1Y -88.34 % -29.60 % 166.23 % -43.65 % -48.97 % -28.98 % -73.08 % -23.53 % -11.52 % -76.67 %
3Y -77.44 % -83.27 % -95.03 % -91.91 % -90.36 % -5.79 % -95.08 % -88.95 % 36.00 % -74.62 %
5Y -97.07 % -96.75 % -95.03 % -98.32 % -90.18 % -87.36 % -99.35 % -92.98 % -88.11 % 21.33 %
10Y -97.56 % -96.75 % -95.03 % -98.32 % -90.18 % -90.07 % -99.76 % -96.80 % -99.64 % 21.33 %
From the beginning -97.56 % -96.75 % -95.03 % -98.32 % -90.18 % -90.07 % -98.57 % -96.80 % -99.64 % 21.33 %

Dividend